APGE
Price
$132.90
Change
+$0.35 (+0.26%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
9.99B
55 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$1.79
Change
-$0.03 (-1.65%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
365.26M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APGE vs PROK

APGE vs PROK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APGE vs. PROK commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (APGE: $132.54 vs. PROK: $1.82)
Brand notoriety: APGE and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 2714% vs. PROK: 89%
Market capitalization -- APGE: $9.96B vs. PROK: $373.46M
APGE [@Biotechnology] is valued at $9.96B. PROK’s [@Biotechnology] market capitalization is $373.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while PROK’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 5 bearish.
  • PROK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both APGE and PROK are a good buy in the short-term.

Price Growth

APGE (@Biotechnology) experienced а +53.78% price change this week, while PROK (@Biotechnology) price change was +8.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

APGE is expected to report earnings on Aug 17, 2026.

PROK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($9.99B) has a higher market cap than PROK($365M). APGE YTD gains are higher at: 75.596 vs. PROK (-18.750). PROK has higher annual earnings (EBITDA): -149.81M vs. APGE (-303.65M). APGE has more cash in the bank: 1.06B vs. PROK (225M). PROK has less debt than APGE: PROK (3.78M) vs APGE (8.05M). PROK has higher revenues than APGE: PROK (889K) vs APGE (0).
APGEPROKAPGE / PROK
Capitalization9.99B365M2,737%
EBITDA-303.65M-149.81M203%
Gain YTD75.596-18.750-403%
P/E RatioN/AN/A-
Revenue0889K-
Total Cash1.06B225M471%
Total Debt8.05M3.78M213%
TECHNICAL ANALYSIS
Technical Analysis
APGEPROK
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
68%
Bearish Trend 12 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIOVX18.42N/A
N/A
Nuveen International Opps W
RKCAX11.43N/A
N/A
Rockefeller Climate Solutions A
PNVAX45.56N/A
N/A
Putnam International Small Cap A
GGOSX8.86N/A
N/A
Goldman Sachs Mid Cap Growth Svc
FSBDX27.62N/A
N/A
Fidelity Series Blue Chip Growth

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+46.65%
SYRE - APGE
49%
Loosely correlated
+13.54%
ORKA - APGE
43%
Loosely correlated
+18.03%
AVBP - APGE
43%
Loosely correlated
+3.02%
XNCR - APGE
41%
Loosely correlated
+10.84%
IMVT - APGE
40%
Loosely correlated
+7.81%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-0.55%
RLYB - PROK
41%
Loosely correlated
-0.69%
SANA - PROK
39%
Loosely correlated
+6.67%
NRIX - PROK
39%
Loosely correlated
+6.27%
APGE - PROK
38%
Loosely correlated
+46.65%
MAZE - PROK
38%
Loosely correlated
-0.43%
More